Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(3):227-232
DOI 10.1590/S0100-72032004000300009
PURPOSE: to identify the risk factors associated with the occurrence of surgical site infection (SSI) in surgeries for the treatment of breast cancer. METHODS: the study was conducted on 140 women submitted to treatment of invasive breast cancer during the period from January 2001 to December 2002. SSI was defined as infection occurring up to 30 days after surgery and was related to the operation, according to the standard criteria adopted by the Centers for Disease Control and Prevention (CDC), USA. SSI were considered to be superficial when they involved only the skin and subcutaneous tissue and deep when they involved deep tissues at the site of incision, such as fascia and muscles. The risk factors related to patient were age, hormonal status, staging, body mass index (BMI) and hemoglobin, and the factors related to surgery were type of operation, time of hospitalization, duration of surgery, and formation of seroma and hematoma. Data concerning numerical nonparametric variables were analyzed by the Mann-Whitney test and quantitative variables were analyzed by the Fisher exact test. RESULTS: of the 140 patients studied, 29 (20.7%) presented SSI, which were superficial in 19 (13.6%) and deep in 10 (71%); 111 patients did not present SSI and represented the control group. The risk factors associated with the patient and the disease were locally advanced stage (odds ratio = 27; 95% CI: 1.1-6.5) and obesity, represented by a mean BMI of 32.2 kg/m² in the patients with SSI and a mean BMI of 27.2 kg/m² in the control group (p<0.0001). The factors related to treatment of the disease were the use of neoadjuvant chemotherapy (odds ratio = 2.7 (95% CI: 1.1-6.5), the duration of surgery, whose median value was 165 minutes for the patients who developed the infection and 137 minutes for the control group (p=0.02), and the number of days of use of the postoperative drain, whose median value was 6 days for the patients with SSI and 5 days for the control group (p=0.048). CONCLUSION: on the basis of the identification of risk factors such as advanced stage, neoadjuvant chemotherapy and obesity, preoperative care for these patients should be emphasized. The use of an accurate surgical technique may reduce the impact of other factors such as surgical time and time of use of the drain.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(3):233-240
DOI 10.1590/S0100-72032004000300010
OBJECTIVE: to evaluate the existence of intra and intercytophathologists disagreement in the analysis of cervical slides previously diagnosed as atypical skin cells with undetermined significance (ASCUS), and the degree of this disagreement. METHODS: a transversal study of 50 cervical slides of Pap smears previously diagnosed as ASCUS, collected in November 2000 in Contagem town. They were analyzed and classified by four cytopathologists according to the first Bethesda system review of 1991 (normal, atrophic alteration, inflammatory alteration, suggestive of LoSIL, suggestive of HiSIL, suggestive of invasive carcinoma and others). After the first analysis, the slides were renumbered in a random order and sent to the same cytophathologists for a new exam. The Kappa test and the weighted Kappa were used in the analysis of the results. RESULTS: there was a high degree of disagreement between the different analyses of the same cytopathologist, varying from 7.8 to 74.4% according to the Kappa test. When a weight of 20% was settled for each degree of disagreement, these values increased from 16.1% for the cytopathologist A to 81.08% for the cytopathologist B. Concerning the comparative analyses made by different examiners the Kappa test values obtained varied from 50.6% to 63.4% in the normal and weighted versions, respectively. CONCLUSIONS: this study confirms the existence of subjectivity in the analysis of the ASCUS category and imprecision in the analysis criteria by the same examiner.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(3):241-245
DOI 10.1590/S0100-72032004000300011
The reduction of mother-to-child transmission (MTCT) of the HIV-1 using zidovudine (ZDV) represents a cornerstone in the prenatal and obstetrical care to these patients. The invasive fetal and obstetric procedures are proscribed in HIV-1 infected pregnant patients, to avoid the increased risk of MTCT of this virus. The authors present a case of an HIV-1 infected woman with recurrent polyhydramnios. Four ultrasound-guided amniotic punctures were performed in the 23rd, 26th, 27th and 29th weeks of gestation, each one draining the respective volumes of 1,800, 1,450, 1,700 and 1,960 ml of clear amniotic fluid. The patient started preterm labor with 30 weeks and 5 days resulting in vaginal delivery of a male neonate weighing 1,690g and measuring 43cm. The baby presented a post natal diagnosis of a sodium-losing nephropathy and was submitted to three negative polymerase chain reaction tests for HIV-1. The authors point out that the option to manage cases of HIV-1 infected pregnancies that could need invasive obstetric procedures should be to give the patient 2 mg//kg of ZDV endovenously before the procedure, in order to avoid MTCT of HIV-1, as it has demonstrated good results in this case.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(3):247-247
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(3):248-248
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(3):249-249
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(3):250-250
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2004;26(3):251-251